The characteristics of alkaline phosphatase (AP) and nitric oxide synthase (NOS) in the lung were investigated using rats challenged with lipopolysaccharide (LPS). Lung homogenates and alveolar lavage fluid were prepared from rats after an intratracheal instillation of 20mg/kg body weight of LPS. AP activities in homogenates were elevated up to 2hr and had recovered to the control level by 6hr. In contrast, those in lavage fluid were significantly decreased after 30min and recovered to the control level by 6hr. Although APs in normal lavage fluid were of the membranous-type in addition to the soluble-type, APs after LPS-challenge were soluble-type only. The 75kDa AP molecule in the homogenate at 2hr after LPS-challenge was increased, in comparison with the control, as was the level of AP activity. In contrast, there was no difference in AP protein level in lavage fluid between the control and LPS-challenged rats. Inducible NOS (iNOS) was obviously induced in lung homogenates by LPS-challenge. Moreover, proteins containing nitrotyrosine as a marker of peroxynitrite were identifiable by Western blot analysis in lavage fluid from rats challenged with LPS. These results indicate that LPS-challenge directly affects the expression and secretion of APs from type II pneumocytes.
INTRODUCTION
Alkaline phosphatases (EC 3.1.3.1., APs) are widely distributed in different organs including the lung, and assays for AP activity and its isozymes in bronchalveolar lavage fluid have been used as a marker of bronchogenic carcinoma, chronic interstitial disorder, and acute respiratory distress syndrome (ARDS).1,2) Four distinct AP genes, a minimum have been identified in humans: liver/bone/kidney type (tissue-unspecific type, UAP), adult intestinal type (TAP), term placental type (PAP), and germ cell AP (placental-like AP, FLAP).
3) The predominant AP isozyme in the lung is UAP produced by type II pneumocytes, 4) but a trace amount of FLAP is expressed in type I pneumocytes.5) In lavage fluid from rats as well, UAP was confirmed to be the predominant isozyme.6) The type II cell is also known to secrete pulmonary surfactants containing APs7) as well as nitric oxide synthase (NOS) which may play a role in host defense against pathogens.8) However, the physiological function of AP remains unclear.
Alveolar type II cells play a very important role in the metabolism of pulmonary surfactants.
Expression of inducible NOS (iNOS) in isolated type II cells appears to be enhanced after exposure to cytokines or lipopolysaccharides (LPS).9) Kristof et al. 10 ) reported unique data: LPS injection in wild-type mice elicits a significant degree of acute lung injury, which is associated with extensive nitrotyrosine formation, and induction of iNOS protein. In contrast, mice lacking the iNOS gene showed a significantly milder degree of acute lung injury and less extensive pulmonary nitrotyrosine formation than did wild-type mice. Thus, a genetically determined absence of NO formation by iNOS attenuates acute lung injury in the murine model of septic shock.
Endotoxin, a lipopolysaccharide (LPS), is a gramnegative bacterial product, and elicits a fulminant inflammatory response. The toxic moiety of lipid A in LPS contains two phosphate groups that are considered to be essential for its biological actions.11) Experimental exposure of the tracheal lining to LPS induces acute respiratory inflammation in the lower respiratory tract, and increases the AP level in lavage fluid.12) LPS exposure leads to alterations in intracellular lamellar inclusions, alveolar surfactant transformation and composition changes, and to altered expression of surfactant proteins (SPs).13) SP-A and SP-D are known to bind to a variety of bacterial endotoxins and to CD 14 on alveolar macrophages and to play a defensive role in LPSinduced ARDS.14) In recent reports, APs have been suggested to be endowed with an activity for endotoxin dephosphorylation activity, e. g., the ubiquitous enzyme AP may function to protect against LPS. 15) In the present study, therefore, we examined the possible expressions of APs and NOSs in the lung from rats challenged with LPS in order to ascertain the significance of APs as a factor protecting against endotoxins.
MATERIALS AND METHODS
Preparations of lung tissues and lavage fluid from rats Wistar male rats (200-250g) were purchased from Saitama Experimental Animals (Saitama, Japan). All constant humidity (50-60%) under a 12-hr light-dark (07:00-19:00 and 19:00-07:00) cycle. Lung tissues and lavage fluid were prepared from rats challenged with LPS (from Escherichia coli 055: B 5, Sigma Chemicals, St. Louis). LPS dissolved in physiological saline was administered to rats anesthetized with diethyl ether by intratracheal instillation delivered at 20 mg/kg by use of a blunted hypodermic 25 G-gauge needle attached to a 3ml-syringe, and the control animals were given the vehicle alone. After instillation, the rats were killed by exsanguination under diethyl ether anesthesia, and the lungs were then removed with the trachea.
Lavage fluid was obtained by lavaging the lungs with Tris-HCl buffered saline (TBS, 10mM, pH 7.5) supplemented with 1mM benzamidine chloride and 0.3mM phenylmethylsulfonylfluoride (PMSF). The lavage fluid were centrifuged at 3,000rpm for 5min assay, AP activity was determined in buffer containing L-homoarginine (L-HArg) or L-phenylalanine (L-Phe) at final concentration of 10mM.17) The preparation was incubated with phosphatidylinositol-specific phospholipase C (3units/ml, PI-PLC) at molecules, and then subjected to catalytic assay and electrophoresis.18) Electrophoretic assay AP zymograms were detected using a polyacrylamide disc gel (Alkphor, Jokoh, Tokyo). The preparation was loaded on a gel at 3mA/tube, and AP active bands in the gel were stained with 5-bromo-3-indolyl phosphate (BIP) as a substrate. 16) Western blot analyses were carried out for AP, eNOS, iNOS, nitrotyrosine and surfactants using their respective antibodies as described previously.16) Antibodies against rat UAP and surfactants were gifts from Dr. D. H. Alpers, Washington University.
Anti-surfactant antibody was prepared from rat intestinal surfactantlike particle (SLP).19) Antibodies against eNOS, iNOS and nitrotyrosine were purchased from Transduction Laboratories (Franklin Lakes, NU, USA). The prepa-ration under reducing conditions were run on 10% polyacrylamide slab gels containing 0.1% SDS, the proteins were transferred to a polyvinylidene difluoride (PVDF) membranes (Milipore Co., Tokyo). After blocking, each membrane was incubated with the respective antibodies for 1hr at room temperature and then for 1hr with peroxide (POD)-conjugated second antibodies. The respective protein bands bearing POD activity on the membranes were detected using an ECL system (ECL Western blotting detection system, Amersham, Arlington Heights).16)
RESULTS

Properties
of APs in rat lung and liver Table 1 compares the enzymatic and physicochemical properties of lung and liver APs. Each value represents means of three experiments.
Although AP in the rat lung apparently shares a number of similarities with bone-type AP, one of the UAPs with respect to amino acid inhibition and so on,6) the present two enzymes were also similar in Km values, pH optimum, molecular weight, and inhibition by amino acids, differing only in thermostability.
However, the relative catalytic activity of pulmonary AP was significantly higher by at least 10-fold than that of liver AP, suggesting the importance of AP activity in the lung.
In a preliminary experiment, we reconfirmed the lung AP reaction with 4-nitrophenyl phosphate to be inhibited in the presence of high LPS concentrations.
This result indicates that LPS is also an AP substrate, described previously by others.15) We then investigated the in vivo relationship between lung AP and LPS. First, the LPS dose instilled in rats was determined.
When rats were challenged with LPS (5, 10, 20 and 40mg/kg body weight), AP activities in lung homogenates at 2hr after instillation increased dose-dependently, while rats given by 40mg/kg died (data not shown). Hence, in the present study, 20mg/kg of LPS was intratracheally instillated.
Levels of AP activities
and AP proteins in lung homogenates and lavage fluid from rats challenged with LPS Lung homogenates and lavage fluid were prepared from rats after LPS-challenge.
Time course of AP activities in the preparations is shown in Fig. 1 . AP activities in homogenates were elevated up to 2hr and had recovered to the control level by 6hr. In contrast, those in lavage fluid were significantly decreased after 30min and had recovered to the control level by 6hr. Levels of AP molecules in the preparations were investigated by Western blot analysis (Fig. 2) . A 75kDa AP molecule in the homogenate at 2hr after LPS-challenge was increased, in comparison with the control, as was the level of AP activity. In addition, a degraded product of 43kDa was also detected at 2hr. In lavage fluid, AP activity was reduced at 30min after LPS-challenge, nevertheless, there was no difference in AP protein level between the control and LPS-challenged rats. Detection of surfactant proteins in lung homogenates and lavage fluid from rats
The preparations were treated with PIPLC to detect membranous-and soluble-type APs by electrophoresis.18) As shown in Fig. 3 , APs in lung homogenates from normal rats and rats challenged with LPS were of the membranous-type and were converted to the solubletype by treatment with PIPLC, as indicated previously in dog liver APs.20) On the other hand, APs in normal lavage fluid contained the soluble-type in addition to the membranous-type.
However, after LPS-challenge, APs were only of the soluble-type, e.g., the APs in rats challenged with LPS were resistant to PIPLCtreatment. In the present study, the lavage fluid preparation for measurement of AP activities contained 0.1% Triton X-100. AP activities in lavage fluid from normal rats not while those in rats given with Triton X-100 were inml. When surfactant is purified from lung homogenates by the method of sucrose density gradient centrifugation, the intracellular surfactant apparently shows a high degree of AP activity. 21) This increase in AP activity with Triton X-100 suggests that AP molecules exist within lipid-particles as a surfactant particle and are solubilized by Triton X-100. Thus, we investigated moieties of surfactant particles by Western blot analysis (Fig. 4) . A preparation from rat intestinal mucosa was also loaded simultaneously as a marker of SLP. Antiserum raised against intestinal SLP has previously been verified. 19 ) Using anti-SLP antibody, two moieties of surfactant particles were detected not only in lung homogenates but also in lavage fluid. Moreover, additional moieties originating from surfactant particles were induced at 2hr after LPS-challenge. Expression of iNOS and detection of nitrotyrosine in lungs of LPS-challenged rats NO is known to be produced at inflammatory sites, and also by type II pneumocytes, via expression of NOS.8) As shown in Fig. 5 , although another bands of low molecular sizes were also observed as contaminated moieties by antibodies used in the present study, expression of neither eNOS of 133kDa nor iNOS of 130kDa, as indicated by arrows, was detected in lavage fluid from normal rats and rats challenged with LPS. In contrast, eNOS was detected in lung homogenates from both groups of rats, but iNOS was expressed in only homogenates from LPS-challenged rats. Furthermore, proteins containing nitrotyrosine as a product generated Lung homogenates and lavage fluid from rats were prepared at 0, 0.5 and 2hr after LPS-challenge.
The preparations were loaded onto a SDS-polyacrylamide slab gel and AP was detected with an anti-AP antibody. by NO were also detected in lavage fluid from LPSchallenged rats (Fig. 6 ).
There was no detectable nitrotyrosine in the cells in lavage fluid from LPSchallenged rats.
Although large amounts of proteins containing nitrotyrosine were detected in lung homogenates, there was no difference between control and LPS-challenged rats (data not shown).
DISCUSSION
In the present study, we reconfirmed that LPS instillation into the rat trachea clearly induces an inflammatory response, and that levels of AP molecules in the lung are directly changed with LPS in parallel with moieties in surfactant particles. These results prompted to speculate that the inflammatory response in the lung induced by LPS occurs as the result of an AP reaction with LPS, as described previously by Poelstra et al.15) LPS, the biologically active constituent of gram-negative bacteria, consists of lipid A, the core oligosaccharide, and a terminal polysaccharide.
Phosphate groups in the LPS molecule are known to be essential for the biological activities of this bacterial product.11) The inflammatory response is initiated by binding of LPS to its receptor.22) Dephosphorylation of LPS by APs then presumably results in a change in LPS conformation and the resulting LPS does not bind to its receptor, which leads to detoxification of LPS by APs. The present study was The preparations from rats at 2hr after LPS-challenge were loaded onto a SDS-polyacrylamide slab gel and SLP moieties were detected with an anti-SLP antibody. N-Lung, normal lung;
LPS-Lung, lung challenged with LPS; Homog., homogenates;
Inte, intestine. Preparations from rats at 2hr after LPS-challenge were loaded onto a SDS-polyacrylamide slab gel and NOSs were detected with (A) anti-eNOS and (B) anti-iNOS antibodies. Homog., homogenates;
Cont., control.
(A) (B) Preparations from rats at 2hr after LPS-challenge were loaded onto a SDS-polyacrylamide slab gel and nitrotyrosine was detected with anti-nitrotyrosine antibody. Cont., control.
thus carried out preliminarily to re-evaluate induction of APs by LPS in the inflammatory response. Serum AP isozymes in healthy subjects consist mainly of liver and bone APs, and assay of serum activity has provided a suitable marker of skeletal and hepatobiliary disorders for clinicians.
However, APs are widely expressed in various organs and the activities are high in human lung as well as in the intestine or placenta.21) We reconfirmed the relative activity of rat lung AP to be higher, by at least 7-fold, than that of liver AP in the present study. This strongly suggests the physiological significance of AP activity in the lung. That UAP is the predominant isozyme in the lung is also interesting, since UAP, unlike the immune system which is a fully evolved host defensive mechanism, is apparently related to a rather primitive defensive system; that is, UAP is thought to be derived from ancestral genes and is not so differentiated as the PAP isozyme. 23) AP is an ectoenzyme that is covalently anchored in the cell membrane via a glycan-PI (GPI) moiety and is cleaved by GPI-phospholipase D (GPI-PLD), PIPLC and/or proteases for conversion to its soluble-type. Capelli et al.24) revealed that the main AP in alveoli forms a complex over 2,000kDa in molecular weight, and suggested that the hydrophobic domain of GPI allows the AP to undergo complex formation.
Our present data support their report; a preparation from normal lavage fluid also contained membranous-type AP. However, LPS-challenge resulted in disappearance of the membranous-type and led to the existence of soluble-type in lavage fluid. LPS may also be related to secretion of AP from type II cells. Furthermore, LPS decreased AP activities in lavage fluid at 30min after instillation.
LPS is known to generate reactive oxygen species in inflammatory reaction.25) We previously demonstrated that reactive oxygen species attacked and inactivated AP molecules.16) The presently observed inactivation of AP in lavage fluid might be due to reactive oxygen species generated by LPS, or to inhibition of the AP reaction with 4-nitrophenyl phosphate by LPS, and/or to product inhibition by phosphate from LPS.15) The inflammatory response was reconfirmed by expression of iNOS and generation of proteins containing nitrotyrosine.
Generation of proteins containing nitrotyrosine was observed in lavage fluid from LPSchallenged rats, but not from normal rats. It was also observed in lung homogenates from both rats, but not in cells in lavage fluid, suggesting that nitrotyrosine may be generated in pneumocytes.
In addition, moieties of surfactant particles containing APs and iNOS were also increased by LPS-challenge.
Nitric oxide is a gas that plays a key role in the regulation of a wide variety of pulmonary functions.8,26) It is also known that tumor of LPS-induced inflammation,27) and LPS-induced does not attenuate intradermal inflammatory cell influx, such that the anti-inflammatory effect of AP is specific for LPS-induced responses. 29) Hence, there is a new strong evidence that changes in AP activity levels in lung homogenates are due to the inflammatory response evoked by LPS.
Although the substrate of APs in the organism remains unclear, pyridoxal 5'-phosphate for UAP30) and phosphorylcholine for IAP31) may be substrates. There is one report describing casein, a protein containing phosphate, in milk as a substrate for APs and intestinal AP as possibly playing a role in casein digestion and absorption in the gastrointestinal tract.32) LPS also contains two phosphate groups, and there is a report that AP is endowed with LPS-dephosphorylating activity at physiological pH and plays an important role in host defense against gram-negative bacterial infections in vitro and in vivo.15) In conclusion, our present study strongly supports previous reports that AP has a protective function against LPS. We are now also interested in mechanism of LPS regulation by intestinal APs in the gastrointestinal tract.
